Hap Trading, LLC Madrigal Pharmaceuticals, Inc. Put Options Transaction History

Hap Trading, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	BUY	$212.22 - $292.96 $2.12 Million - $2.93 Million	10,000 New	10,000 $210 Million
Q4 2019 Feb 11, 2020	SELL	$84.28 - $118.5 $1.74 Million - $2.45 Million	-20,700 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$91.13 - $142.5 $1.89 Million - $2.95 Million	20,700 New	20,700 $93,000

303

22M

819K

644K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.69B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.